Reid Hoffman, co-founder of LinkedIn, will step down from Microsoft's board of directors at the end of the year, concluding nearly a decade of service. Microsoft announced that Hoffman, 58, informed the board on Tuesday of his decision not to seek reelection, and he will remain a director until the company's annual meeting at year-end [1]. Hoffman cited his intention to focus on his new startup, Manas, an 'AI-native biopharmaceutical company,' as the reason for his departure. He discussed this transition with Microsoft CEO Satya Nadella, stating, 'At the end of the year, I should really be transitioning right now to being in founder mode' [1].
Hoffman co-founded LinkedIn in 2002 and sold it to Microsoft for $27 billion in 2016, joining Microsoft's board the following year [1]. He has also been a significant figure in the AI sector, having been an early funder of OpenAI and a co-founder of Inflection, an AI startup. Hoffman left the OpenAI board in 2023 to avoid potential conflicts of interest as Microsoft deepened its partnership with OpenAI [1]. Additionally, Mustafa Suleyman, Hoffman's co-founder at Inflection, joined Microsoft in 2024 and now leads Microsoft AI [1].
Hoffman's recent years have included some controversy. The U.S. Justice Department released documents earlier this year showing communications between Hoffman and financier Jeffrey Epstein, to which Hoffman has apologized for the association [1]. Furthermore, Reuters reported that the Justice Department is investigating a group with ties to Hoffman over contributions to E. Jean Carroll's legal battles against former President Donald Trump. Hoffman addressed this investigation publicly, stating his support for Carroll's lawsuit [1].
The market implications of Hoffman's departure are not explicitly discussed in the article. However, his exit marks the end of an era for Microsoft's board, given his significant role in the company's acquisition of LinkedIn and his influence in the AI sector [1].
CONCLUSION
Reid Hoffman's decision to leave Microsoft's board reflects his shift in focus toward new ventures in AI and biopharmaceuticals. While the article does not detail immediate market reactions, his departure signals a notable leadership change for Microsoft, especially given his history with LinkedIn and AI investments.